Industry recognition is growing for the importance of genomic sequencing for gaining insights vital to an accurate diagnosis and more personalized care.
For the tens of millions of Americans affected by a rare disease, their genes often hold the key to getting the answers they desperately need; from helping them obtain an accurate diagnosis, to identifying which treatments they are likely to respond to. However, accessing these vital genetic insights has not always been prioritized by healthcare providers and payers. Fortunately, this is starting to change.
Published on September 11, 2025 23:06